Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Apr 19, 2022 2:36pm
189 Views
Post# 34614014

RE:Theralase Covid Vaccine with 99.99% Kill Rate!!!

RE:Theralase Covid Vaccine with 99.99% Kill Rate!!!
Infinity wrote: I understand that animal test studies are in progress with NML using PHAC guidelines.  Can anyone of the experts on this board through some light on the 99.99% kill rate?  How would this translate in terms of efficacy and safety (Human Trial stage).

Quote from Dr. Mandel: "Theralase® is pleased to be able to report today that PHAC has demonstrated that light-activated TLD-1433, was effective in rapidly inactivating the SARS-CoV-2 virus by up to 99.99%, compared to control in an in vitro study.  Further research is required to confirm these findings."

 


 

Would like to see that in vitro 99.99% kill rate reproduced in vivo.  While such a high kill rate bodes well for further vaccine development, the vaccine space is crowded with multiple effective vaccines currently in use (particularly the mRNA-based vaccines).  I'd like to see similar attention/funding directed towards the in vivo investigation of TLD 1433 as an anti-viral "treatment" option for both mild & more severe Covid-19 cases.  Finding simpler non-intravenous treatment options in the less competitive outpatient/non-hospitallized space should be similarly prioritized imo.  Currently, Pfizer's Paxlovid is the only simple treatment option (oral) that has shown good efficacy in outpatients.  More options in this space are certainly needed.  Good luck...

<< Previous
Bullboard Posts
Next >>